# AN2 Therapeutics, Inc.: Form 8-K, filed Jun 9, 2026

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: 8-K
- Filed: 2026-06-09
- Accepted by EDGAR: Jun 8, 2026, 18:23 ET
- Period: 2026-06-03
- Accession: 0001193125-26-262264
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000119312526262264/antx-20260603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000119312526262264/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000119312526262264/antx-20260603.htm

Filed Jun 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-262264. Last ingested by Listed: Nov 15, 2026, 04:15 ET. No prices; not investment advice.
